down arrow

Tibet Weixinkang Medicine Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QQ3
  • SHG: 603676
CNY
9.04
0.00 (0.00%)

Sep 22

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tibet Weixinkang Medicine Co., Ltd.

Why is Tibet Weixinkang Medicine Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 32.01%
  • The company has been able to generate a Return on Capital Employed (avg) of 32.01% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of 7.83% and Operating profit at 33.10% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 12.94% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 7.83% and Operating profit at 33.10% over the last 5 years
4
The company has declared Negative results for the last 4 consecutive quarters
  • INTEREST(HY) At CNY 0.15 MM has Grown at 84.86%
  • OPERATING CASH FLOW(Y) Lowest at CNY 272.52 MM
  • ROCE(HY) Lowest at 12.74%
5
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 3.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -23.78% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tibet Weixinkang Medicine Co., Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Tibet Weixinkang Medicine Co., Ltd.
-23.71%
0.22
27.90%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.83%
EBIT Growth (5y)
33.10%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.71
Sales to Capital Employed (avg)
0.84
Tax Ratio
19.63%
Dividend Payout Ratio
60.71%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.24%
ROE (avg)
12.94%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
2.32
EV to EBIT
11.90
EV to EBITDA
10.03
EV to Capital Employed
5.08
EV to Sales
2.21
PEG Ratio
NA
Dividend Yield
1.79%
ROCE (Latest)
42.67%
ROE (Latest)
13.14%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND EQV(HY)

Highest at CNY 2,117.42 MM

-18What is not working for the Company
INTEREST(HY)

At CNY 0.15 MM has Grown at 84.86%

OPERATING CASH FLOW(Y)

Lowest at CNY 272.52 MM

ROCE(HY)

Lowest at 12.74%

INVENTORY TURNOVER RATIO(HY)

Lowest at 8.65 times

RAW MATERIAL COST(Y)

Grown by 9.94% (YoY

NET SALES(Q)

Lowest at CNY 259.41 MM

Here's what is working for Tibet Weixinkang Medicine Co., Ltd.

Cash and Eqv
Highest at CNY 2,117.42 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Tibet Weixinkang Medicine Co., Ltd.

Interest
At CNY 0.15 MM has Grown at 84.86%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 272.52 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio
Lowest at 8.65 times and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales
Lowest at CNY 259.41 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Net Sales
At CNY 259.41 MM has Fallen at -9.43%
over average net sales of the previous four periods of CNY 286.41 MM
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Raw Material Cost
Grown by 9.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading